An investor asked on the investor interaction platform: when can the company’s agent plasma gelatin be listed for sale? Has the approval been completed?
Baotou Dongbao Bio-Tech Co.Ltd(300239) (300239. SZ) said on the investor interaction platform on December 22 that the gelatin of Pharmacopoeia II is carrying out the registration and activation of Association review. For details, you can log in to the drug review center of the State Drug Administration https://www.cde.org.cn./ see
(Daily Economic News)
